Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors

Immunotherapy with immune checkpoint inhibitors (ICIs), while ameliorating lung cancer, can cause infectious diseases, including tuberculosis, in addition to immune-related noninfectious complications. In the clinical setting, the efficacy of ICIs to treat mycobacterial infection remains controversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kohei, Yamamoto, Yuki, Kanai, Osamu, Okamura, Misato, Nakatani, Koichi, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066797/
https://www.ncbi.nlm.nih.gov/pubmed/32190712
http://dx.doi.org/10.1093/ofid/ofaa067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066797/
https://www.ncbi.nlm.nih.gov/pubmed/32190712
http://dx.doi.org/10.1093/ofid/ofaa067

Ejemplares similares